Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98). (Q44023176)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98). |
scientific article |
Statements
1 reference
Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98). (English)
1 reference
Morie A Gertz
1 reference
Montserrat Rue
1 reference
Emily Blood
1 reference
Lynne S Kaminer
1 reference
David H Vesole
1 reference
Philip R Greipp
1 reference
1 October 2004
1 reference
1 reference
45
1 reference
10
1 reference
2047-2055
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference